CLINICAL_TRIALS
trial_result
· 2019-12-16
Clinical Trial Update: Rituximab in Pretreated Elderly or Unfit B-CLL Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating rituximab in pretreated elderly or unfit patients with B-cell chronic lymphocytic leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prof. Dr. Med. Laimonas Griskevicius | Conditions: B-Cell Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-12-16